Bruker (NASDAQ:BRKR) Shares Gap Up on Strong Earnings

Key Points

• Gapped up after earnings — Bruker reported Q earnings of $0.31 per share vs. $0.23 expected and revenue of $823.4M vs. $796.11M, opening at $41.87 vs. the prior close of $38.01 and trading up about 11.5%.
• The company set FY2026 guidance of 2.100–2.150 EPS and declared a quarterly dividend of $0.05 (annual $0.20, yield 0.5%), though its payout ratio is currently -133.33%.
• Analyst sentiment is mixed — MarketBeat shows a consensus rating of Hold with a $49.38 average price target, while institutional investors own roughly 79.5% of the stock and insiders own 27.2%.

Bruker Corporation (NASDAQ:BRKR - Get Free Report) gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $38.01, but opened at $41.87. Bruker shares last traded at $41.5150, with a volume of 333,197 shares changing hands.

The medical research company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.08. The business had revenue of $823.40 million for the quarter, compared to the consensus estimate of $796.11 million. Bruker had a negative net margin of 0.25% and a positive return on equity of 13.56%. The business's quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.47 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS.

Bruker Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 7th. Investors of record on Monday, March 23rd were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, March 23rd. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Bruker's payout ratio is currently -133.33%.

Wall Street Analyst Weigh In

A number of research firms recently commented on BRKR. Weiss Ratings raised shares of Bruker from a "sell (d)" rating to a "sell (d+)" rating in a report on Friday, April 24th. Jefferies Financial Group set a $50.00 price objective on shares of Bruker in a report on Thursday, February 12th. Barclays decreased their price objective on shares of Bruker from $50.00 to $45.00 and set an "overweight" rating on the stock in a report on Tuesday, April 14th. Citigroup decreased their price objective on shares of Bruker from $53.00 to $40.00 and set a "neutral" rating on the stock in a report on Friday, February 13th. Finally, Guggenheim decreased their price objective on shares of Bruker from $58.00 to $50.00 and set a "buy" rating on the stock in a report on Monday, March 30th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $49.38.

Insider Transactions at Bruker

In other Bruker news, VP Mark Munch sold 2,000 shares of Bruker stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $39.90, for a total transaction of $79,800.00. Following the completion of the transaction, the vice president owned 128,443 shares in the company, valued at approximately $5,124,875.70. The trade was a 1.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 27.20% of the company's stock.

Hedge Funds Weigh In On Bruker

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Los Angeles Capital Management LLC acquired a new position in Bruker during the fourth quarter worth about $26,000. Parallel Advisors LLC raised its position in Bruker by 121.0% during the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company's stock worth $41,000 after acquiring an additional 479 shares during the last quarter. Allworth Financial LP raised its position in Bruker by 40.6% during the third quarter. Allworth Financial LP now owns 890 shares of the medical research company's stock worth $29,000 after acquiring an additional 257 shares during the last quarter. Summit Securities Group LLC acquired a new position in Bruker during the fourth quarter worth about $50,000. Finally, Covestor Ltd raised its position in Bruker by 304.6% during the fourth quarter. Covestor Ltd now owns 1,416 shares of the medical research company's stock worth $67,000 after acquiring an additional 1,066 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Bruker Trading Up 11.5%

The business's 50-day simple moving average is $37.13 and its 200-day simple moving average is $41.99. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.73 and a quick ratio of 0.87. The company has a market cap of $6.45 billion, a price-to-earnings ratio of -283.17, a PEG ratio of 2.18 and a beta of 1.12.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker's product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.